5 completed, 2 withdrawn, 1 recruiting, 1 unknown. 9 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 5, Withdrawn 2, Recruiting 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow ASD: new trials by email Literature Review of ASD trials Research Report on ASD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2A Trial of DT402 for Autism Spectrum Disorder DT402 (R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA)) - Autism Spectrum Disorder, ASD | Phase 2 | Completed | Definium Therapeutics US, Inc. | 5 | 2025-12-03 | 2026-11-13 |
| Spironolactone Improved Children With Gene Mutations Related to NCOR .spironolactone - NCOR Gene Mutations, Spironolactone | Phase 2 / Phase 3 | Recruiting | Qilu Hospital of Shandong University | 2 | 2024-10-30 | 2026-05-18 |
| A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder JZP541, Placebo - Irritability Associated With Autism Spectrum Disorder, Autism Spectrum Disorder | Phase 2 | Withdrawn | Jazz Pharmaceuticals | 2023-06-30 | 2024-11-08 | |
| Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT) CP101, Placebo - Autism Spectrum Disorder, Autism | Phase 2 | Withdrawn | Finch Research and Development LLC. | 2020-05-01 | 2021-04-08 | |
| Cannabidiol for ASD Open Trial 98% pure CBD - ASD, Autism Spectrum Disorder | Phase 2 | Completed | NYU Langone Health | 29 | 2019-03-12 | 2024-05-31 |
| Intranasal Vasopressin Treatment in Children With Autism Vasopressin (USP) Injectable Solution [Vasostrict], Placebo - Autism, Autism Spectrum Disorder | Phase 2 / Phase 3 | Completed | Stanford University | 157 | 2018-02-20 | 2026-06-04 |
| Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD L-DOPA versus Placebo, Social Skills Training - ASD | Phase 2 | Unknown | University of California, Los Angeles | 56 | 2017-06-01 | 2023-06-28 |
| Cord Blood Infusion for Children With Autism Spectrum Disorder Cord Blood Infusion, Placebo - Autism Spectrum Disorder, ASD | Phase 2 | Completed | Joanne Kurtzberg, MD | 180 | 2016-09-01 | 2020-06-09 |
| The Effects of Oxytocin on Complex Social Cognition in Autism Spectrum Disorders Syntocinon, Placebo - Autism, ASD | Phase 2 | Completed | Alexander Kolevzon | 30 | 2010-06-18 | 2021-04-15 |
Autism Spectrum Disorder (6) · Autistic Disorder (4) · Child Development Disorders, Pervasive (1)
Mental Disorders (7) · Neurodevelopmental Disorders (7) · Child Development Disorders, Pervasive (6) · Autism Spectrum Disorder (1)
Arginine Vasopressin (1) · N-Methyl-3,4-methylenedioxyamphetamine (1) · Oxytocin (1) · Spironolactone (1) · Vasopressins (1)
Alexander Kolevzon (1) · Definium Therapeutics US, Inc. (1) · Finch Research and Development LLC. (1) · Jazz Pharmaceuticals (1) · Joanne Kurtzberg, MD (1) · NYU Langone Health (1) · Qilu Hospital of Shandong University (1) · Stanford University (1) · University of California, Los Angeles (1)
United States (7) · China (1)
Antonio Y. Hardan, M.D. (1) · Francisco X Castellanos, MD (1) · James T McCracken, MD (1) · Jennifer Bartz, P.h.D. (1) · Joanne Kurtzberg, MD (1) · Karen J. Parker, Ph.D. (1)
PMID 36353577, PMID 37151032, PMID 42204954
R01HD091972 (1)